USE OF IMMUNOPHENOTYPE AS PART OF THE PROGNOSTIC STRATIFICATION FOR CHILDHOOD ALL IN THE FRALLE-93 PROTOCOL

Pui C.H., Bohm F.G., Singh B., Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia, Blood, 75, pp. 174-179, (1990)

Shuster J., Faletta J.M., Pullen D.J., Crist W.M., Humphrey G.B., Dowell B.L., Wharam M.D., Borowitz M., Prognosis factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study, Blood, 75, pp. 166-173, (1990)

Ludwig W.D., Teichmann J.V., Sperling C., Komischke B., Rider J., Reiter A., Odenwald E., Sauter S., Rlehm H., Incidence, clinical characteristics, and prognostic significance of immunological subtypes in childhood acute lymphoblastic leukemia: experience of therapy studies ALL-BFM 83 and 86, Klin. Pediatr., 202, pp. 243-246, (1990)

Schaison G., Sommelet D., Leverger G., Treatment of acute lymphoblastic leukemia. Protocol FRALLE 83–85, Leukemia, 6, suppl. 2, pp. 148-153, (1992)

Rivera G., Ralmondi S.C., Hancock M.L., Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy, Lancet, 337, pp. 61-86, (1991)

Clavell L.A., Gelber R.D., Cohan H.J., Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia, N. Eng. J. Med., 315, pp. 657-663, (1986)

Felckert H.J., Bettoni C., Schrappe M., Reiter A., Ludwig W.D., Bode U., Ebell W., Riehm H., Event-free survival of children with T-cell acute lymphoblastic leukemia after introduction of high dose methotrexate in multicenter trial ALL-BFM 86, Proceedings of ASCO, 12, (1993)

Pui C.H., Behm F.G., Crist W.M., Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia, Blood, 82, pp. 343-362, (1993)

Patte C., Leverger G., Rubie H., Bertrand Y., Coze C., Mechinaud F., Lutz P., Michon J., Baruchel A., Courbon B., High cure rate in B-cell (Burkitt's) leukemia in the LMB 89 protocol of the SFOP, Proceedings of ASCO, 12, (1993)

Reiter A., Schrappe M., Ludwig W.D., Lampert F., Harbott J., Henze G., Niemeyer C.M., Gadner H., Miiller-Weihrich S., Ritter J., Odenwald E., Riehm H., favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group, Blood, 80, pp. 2471-2475, (1992)

Pui C.H., Bohm F.G., Singh B., Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia, Blood, 75, pp. 174-179, (1990)

Shuster J., Faletta J.M., Pullen D.J., Crist W.M., Humphrey G.B., Dowell B.L., Wharam M.D., Borowitz M., Prognosis factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study, Blood, 75, pp. 166-173, (1990)

Ludwig W.D., Teichmann J.V., Sperling C., Komischke B., Rider J., Reiter A., Odenwald E., Sauter S., Rlehm H., Incidence, clinical characteristics, and prognostic significance of immunological subtypes in childhood acute lymphoblastic leukemia: experience of therapy studies ALL-BFM 83 and 86, Klin. Pediatr., 202, pp. 243-246, (1990)

Schaison G., Sommelet D., Leverger G., Treatment of acute lymphoblastic leukemia. Protocol FRALLE 83–85, Leukemia, 6, suppl. 2, pp. 148-153, (1992)

Rivera G., Ralmondi S.C., Hancock M.L., Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy, Lancet, 337, pp. 61-86, (1991)

Clavell L.A., Gelber R.D., Cohan H.J., Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia, N. Eng. J. Med., 315, pp. 657-663, (1986)

Felckert H.J., Bettoni C., Schrappe M., Reiter A., Ludwig W.D., Bode U., Ebell W., Riehm H., Event-free survival of children with T-cell acute lymphoblastic leukemia after introduction of high dose methotrexate in multicenter trial ALL-BFM 86, Proceedings of ASCO, 12, (1993)

Pui C.H., Behm F.G., Crist W.M., Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia, Blood, 82, pp. 343-362, (1993)

Patte C., Leverger G., Rubie H., Bertrand Y., Coze C., Mechinaud F., Lutz P., Michon J., Baruchel A., Courbon B., High cure rate in B-cell (Burkitt's) leukemia in the LMB 89 protocol of the SFOP, Proceedings of ASCO, 12, (1993)

Reiter A., Schrappe M., Ludwig W.D., Lampert F., Harbott J., Henze G., Niemeyer C.M., Gadner H., Miiller-Weihrich S., Ritter J., Odenwald E., Riehm H., favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group, Blood, 80, pp. 2471-2475, (1992)